Table 3.
Assessment tool for animal models of Takotsubo syndrome.
| aClinically relevant trigger/experimental design |
| aAkinetic and/or dyskinetic regional wall motion abnormalities |
| aAcute onset |
| aTransient natural course |
| aIncreased levels of cardiac biomarkers |
| aNew ECG-changes |
| Genetically modified animal is not required |
| Low mortality |
| Reproducible |
Definition and criteria for TS in animal models.